Cited by 216Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

Open access

Bionic Pancreas Research Group·2022·New England Journal of Medicine

DOI 10.1056/nejmoa2205225PMC PMC10028490

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation. In contrast, the bionic pancreas is initialized only on the basis of body weight, makes all dose decisions and delivers insulin autonomously, and uses meal announcements without carbohydrate counting. METHODS: In this 13-week, multicenter, randomized trial, we randomly assigned in a 2:1 ratio persons at least 6 years of age with type 1 diabetes either to receive bionic pancreas treatment with insulin aspart or insulin lispro or to receive standard care (defined as any insulin-delivery method with unblinded, real-time continuous glucose monitoring). The primary outcome was the glycated hemoglobin level at 13 weeks. The key secondary outcome was the percentage of time that the glucose level as assessed by continuous glucose monitoring was below 54 mg per deciliter; the prespecified noninferiority limit for this outcome was 1 percentage point. Safety was also assessed. RESULTS: A total of 219 participants 6 to 79 years of age were assigned to the bionic-pancreas group, and 107 to the standard-care group. The glycated hemoglobin level decreased from 7.9% to 7.3% in the bionic-pancreas group and did not change (was at 7.7% at both time points) in the standard-care group (mean adjusted difference at 13 weeks, -0.5 percentage points; 95% confidence interval [CI], -0.6 to -0.3; P<0.001). The percentage of time that the glucose level as assessed by continuous glucose monitoring was below 54 mg per deciliter did not differ significantly between the two groups (13-week adjusted difference, 0.0 percentage points; 95% CI, -0.1 to 0.04; P<0.001 for noninferiority). The rate of severe hypoglycemia was 17.7 events per 100 participant-years in the bionic-pancreas group and 10.8 events per 100 participant-years in the standard-care group (P = 0.39). No episodes of diabetic ketoacidosis occurred in either group. CONCLUSIONS: In this 13-week, randomized trial involving adults and children with type 1 diabetes, use of a bionic pancreas was associated with a greater reduction than standard care in the glycated hemoglobin level. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; ClinicalTrials.gov number, NCT04200313.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa2205225

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., Schoelwer, M., Ruedy, K. J., Jost, E., Carria, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004736 · Cited by 455
Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study
Pettus, J., Zhou, F. L., Shepherd, L. C., Preblick, R., Hunt, P. R., Paranjape, S., Miller, K. M., & Edelman, S. V. (2019) · Diabetes Care · doi:10.2337/dc19-0830 · Cited by 162
Accuracy of Carbohydrate Counting in Adults
Meade, L. T., & Rushton, W. E. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.3.142 · Cited by 71
Current Status and Emerging Options for Automated Insulin Delivery Systems
Forlenza, G. P., & Lal, R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0514 · Cited by 70
Positive impact of the bionic pancreas on diabetes control in youth 6-17 years old with type 1 diabetes: a multicenter randomized trial
Bionic Pancreas Research Group, Messer, L. H., Buckingham, B. A., Cogen, F., Daniels, M., Forlenza, G., Jafri, R. Z., Mauras, N., Muir, A., Wadwa, R. P., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0201.pub · Cited by 59
A multicenter randomized trial evaluating fast-acting insulin aspart in the bionic pancreas in adults with type 1 diabetes
Bionic Pancreas Research Group, Beck, R. W., Russell, S. J., Damiano, E. R., El-Khatib, F. H., Ruedy, K. J., Balliro, C., Li, Z., & Calhoun, P. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0167 · Cited by 40
A multicenter randomized trial evaluating the insulin-only configuration of the bionic pancreas in adults with type 1 diabetes
Bionic Pancreas Research Group, Kruger, D., Kass, A., Lonier, J., Pettus, J., Raskin, P., Salam, M., Trikudanathan, S., Zhou, K., Russell, S. J., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0200 · Cited by 38
Self-citation
Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears
Kanapka, L. G., Lum, J. W., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0548 · Cited by 35

Show all 10 references

Sorted by citations

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s009 · Cited by 728
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s009 · Cited by 662
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Type 1 diabetes
Quattrin, T., Mastrandrea, L. D., & Walker, L. S. K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00223-4 · Cited by 292
9. pharmacologic approaches to glycemic treatment: standards of care in diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s009 · Cited by 263
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., Schoelwer, M., Lum, J., Kollman, C., Beck, R. W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2210834 · Cited by 191
Diabetes and cognitive function: An evidence-based current perspective
Sebastian, M. J., Khan, S. K. A., Pappachan, J. M., & Jeeyavudeen, M. S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i2.92 · Cited by 115
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery
Biester, T., Berget, C., Boughton, C. K., Cudizio, L., Ekhlaspour, L., Hilliard, M. E., Reddy, L., Sap, S. N. U., Schoelwer, M. J., Sherr, J. L., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543034 · Cited by 114
Artificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes
Forlenza, G. P., DeSalvo, D. J., Aleppo, G., Wilmot, E. G., Berget, C., Huyett, L. M., Hadjiyianni, I., Méndez, J. J., Conroy, L. R., Ly, T. T., et al. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0578 · Cited by 99
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study
Crabtree, T. S. J., Griffin, T. P., Yap, Y. W., Narendran, P., Gallen, G., Furlong, N. J., CRANSTON, I. C., Chakera, A. J., Philbey, C., Karamat, M. A., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0635 · Cited by 95
New advances in type 1 diabetes
Subramanian, S., Khan, F. N., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 105
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.
Kudva, Y. C., Raghinaru, D., Lum, J. W., Graham, T. E., Liljenquist, D., Spanakis, E. K., Pasquel, F. J., Ahmann, A., Ahn, D. T., Aleppo, G., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2415948 · Cited by 83
The Artificial Pancreas and Type 1 Diabetes
Nwokolo, M., & Hovorka, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad068 · Cited by 99
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis
Molfetta, S. D., Gioia, L. D., Caruso, I., Cignarelli, A., Green, S. C., Natale, P., Strippoli, G. F., Sorice, G. P., Perrini, S., Natalicchio, A., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3842 · Cited by 88
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Moser, O., Zaharieva, D. P., Adolfsson, P., Battelino, T., Bracken, R. M., Buckingham, B. A., Danne, T., Davis, E. A., Dovč, K., Forlenza, G. P., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06308-z · Cited by 80
Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials
Godoi, A., Marques, I. R., Padrão, E. M. H., Mahesh, A., Hespanhol, L. C., Júnior, J. E. R. L., de Souza, I. A. F., Moreira, V. C. S., Silva, C. H., Miyawaki, I. A., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01144-4 · Cited by 79
Digital Technology for Diabetes
Hughes, M. S., Addala, A., & Buckingham, B. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215899 · Cited by 59
The role of automated insulin delivery technology in diabetes
Boughton, C. K., & Hovorka, R. (2024) · Diabetologia · doi:10.1007/s00125-024-06165-w · Cited by 57
Positive impact of the bionic pancreas on diabetes control in youth 6-17 years old with type 1 diabetes: a multicenter randomized trial
Bionic Pancreas Research Group, Messer, L. H., Buckingham, B. A., Cogen, F., Daniels, M., Forlenza, G., Jafri, R. Z., Mauras, N., Muir, A., Wadwa, R. P., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0201.pub · Cited by 59
Real-world evidence of automated insulin delivery system use
Considine, E. G., & Sherr, J. L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0442 · Cited by 59
Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade
Karakus, K. E., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2023) · Diabetes Care · doi:10.2337/dc23-0495 · Cited by 52
Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Fan, W., Deng, C., Xu, R., Liu, Z., Leslie, R. D., Zhou, Z., & Li, X. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0130 · Cited by 52
The History, Evolution and Future of Continuous Glucose Monitoring (CGM)
Bender, C., Vestergaard, P., & Cichosz, S. L. (2025) · Diabetology · doi:10.3390/diabetology6030017 · Cited by 43
Automated insulin delivery in older adults with type 1 diabetes
Kudva, Y. C., Henderson, R. J., Kanapka, L. G., Weinstock, R. S., Rickels, M. R., Pratley, R. E., Chaytor, N., Janess, K., Desjardins, D., Pattan, V., et al. (2025) · NEJM Evidence · doi:10.1056/evidoa2400200 · Cited by 45
Human-machine co-adaptation to automated insulin delivery: a randomised clinical trial using digital twin technology
Kovatchev, B. P., Colmegna, P. H., Pavan, J., C., J. L. D., Villa-Tamayo, M. F., Koravi, C. L. K., Santini, G., Alix, C., Stumpf, M. M., & Brown, S. A. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01679-y · Cited by 50
Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases
ALMURASHI, A. M., Rodriguez, E., & Garg, S. K. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00348-3 · Cited by 55
A multicenter randomized trial evaluating fast-acting insulin aspart in the bionic pancreas in adults with type 1 diabetes
Bionic Pancreas Research Group, Beck, R. W., Russell, S. J., Damiano, E. R., El-Khatib, F. H., Ruedy, K. J., Balliro, C., Li, Z., & Calhoun, P. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0167 · Cited by 40
Economic Perspective of the Use of Wearables in Health Care: A Systematic Review
Velasquez, G. D. D. S., Borna, S., Maniaci, M. J., Coffey, J. D., Haider, C. R., Demaerschalk, B. M., & Forte, A. J. (2024) · Mayo Clinic Proceedings Digital Health · doi:10.1016/j.mcpdig.2024.05.003 · Cited by 50
A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial
Dovč, K., Bergford, S., Fröhlich-Reiterer, E. E., Zaharieva, D. P., Potočnik, N., Müller, A., Lenarčič, Ž., Calhoun, P. M., Fritsch, M., Sourij, H., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0178 · Cited by 43
Real-World Glycemic Outcomes with Early Omnipod 5 Use in Youth with Type 1 Diabetes
Marks, B. E., Meighan, S. S., Zehra, A., Douvas, J. L., Rearson, A., Suresh, R., Brown, E. A., & Wolf, R. M. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0337 · Cited by 39
A multicenter randomized trial evaluating the insulin-only configuration of the bionic pancreas in adults with type 1 diabetes
Bionic Pancreas Research Group, Kruger, D., Kass, A., Lonier, J., Pettus, J., Raskin, P., Salam, M., Trikudanathan, S., Zhou, K., Russell, S. J., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0200 · Cited by 38
Self-citation
First use of open-source automated insulin delivery AndroidAPS in full closed-loop scenario: Pancreas4ALL randomized pilot study
Petruzelkova, L., Neuman, V., Plachy, L., Kozak, M., Obermannova, B., Kolouskova, S., Pruhova, S., & Sumnik, Z. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0562 · Cited by 40
Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm
Kovatchev, B. P., Castillo, A., Pryor, E. C., Kollar, L. L., Barnett, C. L., DeBoer, M. D., Brown, S. A., & for the NAP Study Team (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0469 · Cited by 43
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Shah, V. N., Peters, A. L., Umpierrez, G. E., Sherr, J. L., Akturk, H. K., Aleppo, G., Bally, L., Cengiz, E., Cinar, A., Dungan, K., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241291512 · Cited by 36
Automated Insulin Delivery Systems and Glucose Management in Children and Adolescents With Type 1 Diabetes
Visser, H. S. D., Waraich, S., Chhabra, M., Yamamoto, J. M., Zenlea, I. S., Askin, N., Rabbani, R., McGavock, J., TEAM Trial Patient Coresearchers, Greenberg, D. T., et al. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.2740 · Cited by 39
Efficacy of automated insulin delivery systems in people with type 1 diabetes: a systematic review and network meta-analysis of outpatient randomised controlled trials
Stahl‐Pehe, A., Mashhadi, N. S., Wirth, M., Schlesinger, S., Kuß, O., Holl, R. W., Bächle, C., Warz, K.-D., Bürger-Büsing, J., Spörkel, O., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103190 · Cited by 38
The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes
Lynch, J. L., Kanapka, L. G., Russell, S. J., Damiano, E. R., El-Khatib, F. H., Ruedy, K. J., BALLIRO, C. A., Calhoun, P. M., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0341 · Cited by 31
Psychosocial Impact of the Insulin-Only iLet Bionic Pancreas for Adults, Youth, and Caregivers of Youth with Type 1 Diabetes
Weissberg-Benchell, J. A., Vesco, A. T., Shapiro, J. B., Calhoun, P. M., Damiano, E. R., Russell, S. J., Li, Z., El-Khatib, F. H., Ruedy, K. J., BALLIRO, C. A., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0238 · Cited by 31
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
Jacobsen, L. M., Sherr, J. L., Considine, E. G., Chen, A., Peeling, S., Hulsmans, M., Charleer, S., Urazbayeva, M., Tosur, M., ALAMARIE, S. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00358-x · Cited by 34
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
Thrasher, J. R., Arrieta, A., Niu, F., Cameron, K. R., Cordero, T. L., Shin, J., Rhinehart, A. S., & Vigersky, R. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0453 · Cited by 29
Hybrid Closed Loop Systems Improve Glycemic Control and Quality of Life in Historically Minoritized Youth with Diabetes
Marks, B. E., Grundman, J., Meighan, S. S., Monaghan, M. C., Streisand, R. M., & PERKINS, A. G. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0450 · Cited by 27
Closed-loop systems: recent advancements and lived experiences
Kadiyala, N., Hovorka, R., & Boughton, C. K. (2024) · Expert Review of Medical Devices · doi:10.1080/17434440.2024.2406901 · Cited by 29
Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ
Karakus, K. E., Klein, M. P., Aktürk, H. K., & Shah, V. N. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01592-9 · Cited by 25
Use of diabetes technology in children
Schoelwer, M. J., DeBoer, M. D., & Breton, M. D. (2024) · Diabetologia · doi:10.1007/s00125-024-06218-0 · Cited by 27
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump Therapy
Coutant, R., Bismuth, É., Bonnemaison, É., Dalla‐Vale, F., Morinais, P., Perrard, M., Trely, J., Faure, N., Bouhours‐Nouet, N., Levaillant, L., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0518 · Cited by 25
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis– Related Diabetes
Sherwood, J. S., Castellanos, L. E., O’Connor, M. Y., BALLIRO, C. A., HILLARD, M. A., Gaston, S. G., Bartholomew, R. A., Greaux, E. G., Sabean, A., Zheng, H., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1411 · Cited by 22
Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
Friedman, J. G., Coyne, K., Aleppo, G., & Szmuilowicz, E. D. (2023) · Endocrine Connections · doi:10.1530/ec-23-0085 · Cited by 22
The Evolution of Diabetes Technology – Options Toward Personalized Care
Zahid, M., Dowlatshahi, S., Kansara, A., & Sadhu, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.007 · Cited by 22
Development and Future of Automated Insulin Delivery (AID) Systems
Garg, S. K., & MCVEAN, J. J. F. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0467 · Cited by 25
Diabetes technology in people with diabetes and advanced chronic kidney disease
Galindo, R. J., Soliman, D., Cherñavvsky, D. R., & Rhee, C. M. (2024) · Diabetologia · doi:10.1007/s00125-024-06244-y · Cited by 21
Closed-Loop Control, Artificial Intelligence–Based Decision-Support Systems, and Data Science
Nimri, R., Phillip, M., Clements, M. A., & Kovatchev, B. P. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2505 · Cited by 22
Evaluation of an Automated Priming Bolus for Improving Prandial Glucose Control in Full Closed Loop Delivery
Moscoso-Vásquez, M., Colmegna, P. H., Barnett, C. L., Fuller, M. R., Koravi, C. L. K., Brown, S. A., DeBoer, M. D., & Breton, M. D. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0315 · Cited by 19
Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada
Cohen, E., Tsoukas, M. A., Legault, L., Vallis, M., Oettingen, J. E. V., Palisaitis, E., Odabassian, M., Yale, J., Garfield, N., Gouchie‐Provencher, N., et al. (2024) · The Lancet Digital Health · doi:10.1016/s2589-7500(24)00092-x · Cited by 19
Evidence from clinical trials on high-risk medical devices in children: a scoping review
Guerlich, K., Patro-Gołąb, B., Dworakowski, P., Fraser, A. G., Kammermeier, M., Melvin, T., & Koletzko, B. V. (2023) · Pediatric Research · doi:10.1038/s41390-023-02819-4 · Cited by 17
Barriers and Facilitators of Self-Management in Older People with Type 1 Diabetes: A Narrative Review Focusing on Cognitive Impairment
Fonseca, L. M., Schmidt, J. J., Snoek, F. J., Weinstock, R. S., Chaytor, N. S., Stuckey, H. L., Ryan, C. M., & van Duinkerken, E. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s410363 · Cited by 20
Recent advances in diabetes technology and activities of the American Diabetes Association Diabetes Technology Interest Group
Akturk, H. K., American Diabetes Association Diabetes Technology Interest Group, Aloi, J., Shah, V. N., Akturk, H. K., McKee, A. M., Ekhlaspour, L., Kim, S., & Everett, E. (2024) · Clinical Diabetes · doi:10.2337/cd23-0080 · Cited by 16
Materials and System Design for Self‐Decision Bioelectronic Systems
Zeng, Q., Liu, H., Zhang, Y., Zheng, Y., Ding, X., Zhu, M., Shi, G., Wang, Y., Haick, H., & Zhang, M. (2026) · Advanced Materials · doi:10.1002/adma.202521164 · Cited by 23
Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care
Hughes, M. S., Pasquel, F. J., Davis, G. M., Lal, R., Buckingham, B. A., Boughton, C. K., Brown, S. A., & Bally, L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0343 · Cited by 13
The insulin-only bionic pancreas improves glycemic control in non-Hispanic White and minority adults and children with type 1 diabetes
Castellanos, L. E., Russell, S. J., Damiano, E. R., Beck, R. W., Shah, V. N., Bailey, R., Calhoun, P., Bird, K., Mauras, N., Bionic Pancreas Research Group, et al. (2023) · Diabetes Care · doi:10.2337/dc22-1478 · Cited by 11
Self-citation
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Jacobs, P. G., Levy, C. J., Brown, S. A., Riddell, M. C., Çınar, A., Boughton, C. K., Breton, M. D., Dassau, E., Forlenza, G. P., Henderson, R. J., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251338754 · Cited by 17
Testing the Real-World Accuracy of the Dexcom G6 Pro CGM During the Insulin-Only Bionic Pancreas Pivotal Trial
Marak, M. C., Calhoun, P. M., Damiano, E. R., Russell, S. J., Ruedy, K. J., & Beck, R. W. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0287 · Cited by 11
Advances in diabetes technology to improve the lives of people with cystic fibrosis
Scully, K. J., Marks, B. E., & Putman, M. S. (2024) · Diabetologia · doi:10.1007/s00125-024-06223-3 · Cited by 11
Real-Life Use of Automated Insulin Delivery in Individuals With Type 2 Diabetes
Fabris, C., & Kovatchev, B. P. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241274786 · Cited by 11
A Call-to-Action to Eliminate Barriers to Accessing Automated Insulin Delivery Systems for People with Type 1 Diabetes
Saboo, B., Garg, S. K., Bergenstal, R. M., Battelino, T., Ceriello, A., Choudhary, P., de Bock, M. I., Elbarbary, N. S., Forlenza, G. P., Gómez, A. M., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0028 · Cited by 12
A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People With Type 1 Diabetes
Gera, S., Iyer, J., Meighan, S. S., March, C. A., & Marks, B. E. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.004 · Cited by 13
Exploring Technology’s Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review
McClure, R. D., Talbo, M. K., Bonhoure, A., Molveau, J., South, C. A., Lebbar, M., & Wu, Z. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01534-6 · Cited by 16
NOVEL AGENTS IN THE MANAGEMENT OF DIABETES AND RISK OF WORSENING DIABETIC RETINOPATHY
Rajagopal, R., & McGill, J. B. (2024) · Retina · doi:10.1097/iae.0000000000004252 · Cited by 10
Fully automated insulin delivery systems in type 1 diabetes: A systematic review and meta‐analysis
Fan, W., Deng, C., Xu, R., Liu, Z., He, Y., Zhou, Z., & Li, X. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16499 · Cited by 10
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Moser, O., Zaharieva, D. P., Adolfsson, P., Battelino, T., Bracken, R. M., Buckingham, B. A., Danne, T., Davis, E. A., Dovč, K., Forlenza, G. P., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000542287 · Cited by 9
DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial
Fang, M., Wang, D., Rebholz, C. M., Echouffo-Tcheugui, J. B., Tang, O., Wang, N., MITCHELL, C. M., Pilla, S. J., Appel, L. J., & Selvin, E. (2025) · Nature Medicine · doi:10.1038/s41591-025-03823-3 · Cited by 10
Emerging Technologies and Therapeutics for Type 1 Diabetes
Aktürk, H. K., & McKee, A. M. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.07.002 · Cited by 9
Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults With Type 1 Diabetes: Key Learnings From a Safety Net Diabetes Clinic Program
Steenkamp, D., Brouillard, E., Aia, C., Fantasia, K. L., Sullivan, C. A. W., Atakov-Castillo, A., & Wolpert, H. A. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.04.001 · Cited by 11
Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes
Karakus, K. E., Aktürk, H. K., Snell‐Bergeon, J. K., & Shah, V. N. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251318740 · Cited by 8
Closed-loop therapy: recent advancements and potential predictors of glycemic outcomes
Royston, C., Hovorka, R., & Boughton, C. K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2492363 · Cited by 11
Assessing the Accuracy of Continuous Glucose Monitoring Metrics: The Role of Missing Data and Imputation Strategies
Cichosz, S. L., Kronborg, T., Hangaard, S., Vestergaard, P., & Jensen, M. H. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0102 · Cited by 8
Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
Bergenstal, R. M., Heller, A., Breton, M. D., Vigersky, R. A., Brown, S. A., Forlenza, G. P., Sherr, J. L., Hovorka, R., Russell, S. J., Damiano, E. R., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251342239 · Cited by 9
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial
Wilmot, E. G., Beltrand, J., Guerci, B., Berot, A., Hanaire, H. P., Bismuth, É., Gillard, P., Saade, M., Joubert, M., Salet, R., et al. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00364-x · Cited by 8
Automated glycemic control with a bionic pancreas for type 1 diabetes mellitus: A systematic review and meta-analysis
Oktavian, P., Budi, D. S., Wibowo, I. N., Rusuldi, R. C. R., Kusumawardhani, A. D., Wafa, I. A., Rahman, H. R., Pratama, N. R., & Wibisono, S. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102847 · Cited by 8
Postprandial glucose‐management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence
Jafar, A., & Pasqua, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15463 · Cited by 10
Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas
Howard, K. R., Garza, K. P., Feldman, M. A., & Weissberg-Benchell, J. A. (2024) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsae022 · Cited by 8
Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial
Oser, S. M., Putman, M. S., Russell, S. J., Westfeldt, E. B., Huss, K. B., Prince, B. K., Parascando, J. A., O’Connor, M. Y., Sabean, A., Ashley, A. L., et al. (2025) · Clinical Diabetes · doi:10.2337/cd24-0104 · Cited by 7
Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe
Berget, C., Annan, F., Biester, T., Choudhary, P., Forlenza, G. P., Peters, A. L., Renard, É., & Deiss, D. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16321 · Cited by 8
A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial
Kobayati, A., Fathi, A. E., Garfield, N., Legault, L., Jafar, A., Yale, J., Tsoukas, M. A., & Haidar, A. (2025) · Nature Communications · doi:10.1038/s41467-025-63671-0 · Cited by 7
Algorithm-Driven Initiation and Adaptation of Hybrid Closed-Loop in Young Children with Type 1 Diabetes: A Pilot Study
Pavan, J., Cobry, E. C., Reed, Z. W., Villa-Tamayo, M. F., C., J. L. D., DeBoer, M. D., Schoelwer, M. J., Jost, E., KINGMAN, R. S., Holmes, V. F., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0650 · Cited by 8
Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled Trial
Wilkinson, T., Nanayakkara, N., Burren, D., Jenkins, A., Williman, J. A., Keesing, C., Boyle, E., Elghattis, Y., Bennett, A., Gunn, T. C., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261423558 · Cited by 6
Concordance of Central Laboratory Hemoglobin A1c Measurements from Capillary Kits Compared to Venous Draws in the Insulin-Only Bionic Pancreas Pivotal Trial
Li, Z., Calhoun, P. M., Ruedy, K. J., & Beck, R. W. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0094 · Cited by 7
Registration and Real-Life Studies on Automated Insulin Delivery Systems
Aktürk, H. K., Brown, S. A., Beck, R. W., Sherr, J. L., Bergenstal, R. M., Kovatchev, B. P., Vigersky, R. A., Breton, M. D., Hovorka, R., Klonoff, D. C., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251334993 · Cited by 6
Registration and Real-Life Studies on Automated Insulin Delivery Systems
Aktürk, H. K., Brown, S. A., Beck, R. W., Sherr, J. L., Bergenstal, R. M., Kovatchev, B. P., Vigersky, R. A., Breton, M. D., Hovorka, R., Klonoff, D. C., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0130 · Cited by 6
Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
Newman, C., Ero, A., & Dunne, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1109825 · Cited by 6
Closed-loop Artificial Pancreas Development: A Review
Glumčević, S., Mašetić, Z., & Viteškić, B. (2023) · International Convention on Information and Communication Technology, Electronics and Microelectronics · doi:10.23919/mipro57284.2023.10159633 · Cited by 6
Safety and performance of a hybrid closed-loop insulin delivery system with carbohydrate suggestion in adults with type 1 diabetes prone to hypoglycemia
Mesa, A., Beneyto, A., José, J., Viaplana, J., Bondía, J., Vehı́, J., Conget, I., & Giménez, M. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110956 · Cited by 7
Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force
Hoppe, J. E., Sjoberg, J., Hong, G., Poch, K. R., Zemanick, E. T., Thee, S. A., Edmondson, C. L., Patel, D. R., Sathe, M., Borowitz, D., et al. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.02.011 · Cited by 7
First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life Data
Benhamou, P., Adenis, A., Lablanche, S., Franc, S., Amadou, C., Penfornis, A., Kariyawasam, D., Beltrand, J., & Charpentier, G. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231186976 · Cited by 6
Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes
Deng, Y., Arao, K., Mantzoros, C. S., & Karniadakis, G. E. (2026) · Smart Health · doi:10.1016/j.smhl.2026.100633 · Cited by 8
Metabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18800.ac · Cited by 5
An mHealth Text Messaging Program Providing Symptom Detection Training and Psychoeducation to Improve Hypoglycemia Self-Management: Intervention Development Study
Lin, Y. K., Aikens, J. E., de Zoysa, N., Hall, D., Funnell, M. M., Nwankwo, R. B., Kloss, K., DeJonckheere, M. J., Pop‐Busui, R., Piatt, G., et al. (2023) · JMIR Formative Research · doi:10.2196/50374 · Cited by 5
Efficacy of automated insulin delivery (AID) systems in type 1 diabetes: protocol of a systematic review and network meta-analysis of outpatient randomised controlled trials
Stahl‐Pehe, A., Schlesinger, S., Kuß, O., Mashhadi, N. S., Bächle, C., Warz, K.-D., Bürger-Büsing, J., Holl, R. W., Spörkel, O., & Rosenbauer, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074317 · Cited by 7
Towards a new taxonomy of preterm birth
Stevenson, D. K., Chang, A. L., Wong, R. J., Reiss, J. D., Gaudilliere, B. L., Sylvester, K. G., Ling, X. B., Angst, M. S., Shaw, G. M., Katz, M., et al. (2024) · Journal of Perinatology · doi:10.1038/s41372-024-02183-z · Cited by 5

Authors: Bionic Pancreas Research Group
Affiliations: Boston University (US)
Corresponding author: Bionic Pancreas Research Group
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2022-09-29
Volume: 387
Issue: 13
Pages: 1161-1172
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa2205225
PMC: PMC10028490
OpenAlex: W4297519371
Cited by: 216
References: 10
Citations by year: 2026: 41 · 2025: 63 · 2024: 55 · 2023: 50 · 2022: 7
FWCI: 32.40
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (1UC4DK108612-01)
Beta Bionics, Inc
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: bionic pancreas, type 1 diabetes, artificial pancreas, HbA1c, hypoglycemia, continuous glucose monitoring, insulin aspart, insulin lispro, non-inferiority, HbA1c reduction, diabetic ketoacidosis
MeSH terms: Adolescent, Adult, Aged, Bionics, Blood Glucose, Child, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Middle Aged, Blood Glucose Self-Monitoring, Young Adult, Insulin Aspart, Insulin Lispro

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks